Investor profile
Innosuisse has backed 10 European tech companies across 10 funding rounds between 2021 and 2026, joining rounds totalling €66M. Most active in Healthtech and Cleantech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Jua | Switzerland | 1 | €15M |
| Unbound Potential | Switzerland | 1 | €14M |
| Distran | Switzerland | 1 | €10M |
| Chiral Nano | Switzerland | 1 | €10M |
| RocketVax | Switzerland |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Jua | Other | €15M | 2024-02 |
| Unbound Potential | Pre-Seed | €14M | 2025-09 |
| Distran | Series B | €10M | 2023-06 |
| Chiral Nano |
| 1 |
| €6.7M |
| Librec | Switzerland | 1 | €2.8M |
| Araris Biotech | Switzerland | 1 | €2.5M |
| KUORI | Switzerland | 1 | €2.3M |
| AMPLY | Ireland | 1 | €1.6M |
| Biosimo | Switzerland | 1 | €810k |
| €10M |
| 2026-02 |
| RocketVax | Series A | €6.7M | 2021-08 |
| Librec | Seed | €2.8M | 2021-08 |
| Araris Biotech | Other | €2.5M | 2023-05 |
| KUORI | Other | €2.3M | 2023-01 |
| AMPLY | Grant | €1.6M | 2024-02 |
| Biosimo | Pre-Seed | €810k | 2022-11 |
